Diana Maria Chiorean

Dr. Diana Maria Chiorean

Spitalul Clinic Judetean de Urgenta Târgu Mureş, Târgu Mureş, Romania
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
IOIoan Oala
Ioan Oala
Melinda Ildiko MitranoviciMelinda Ildiko Mitranovici
Melinda Ildiko Mitranovici
Diana Maria ChioreanDiana Maria Chiorean
Diana Maria Chiorean
TITraian Irimia
Traian Irimia
ACAndrada Ioana Crisan
Andrada Ioana Crisan
LPLucian Puscasiu
Lucian Puscasiu
Endometriosis is a chronic inflammatory disease, which explains the pain that such patients report. Currently, we are faced with ineffective, non-invasive diagnostic methods and treatments that come with multiple side effects and high recurrence rates for both the disease and pain. These are the reasons why we are exploring the possibility of the involvement of pro-inflammatory and anti-inflammatory molecules in the process of the appearance of endometriosis. Cytokines play an important role in the progression of endometriosis, influencing cell proliferation and differentiation. Pro-inflammatory molecules are found in intrafollicular fluid. They have an impact on the number of mature and optimal-quality oocytes. Endometriosis affects fertility, and the involvement of endometriosis in embryo transfer during in vitro fertilization (IVF) is being investigated in several studies. Furthermore, the reciprocal influence between anti-inflammatory and pro-inflammatory cytokines and their role in the pathogenesis of endometriosis has been assessed. Today, we can affirm that pro-inflammatory and anti-inflammatory cytokines play roles in survival, growth, differentiation, invasion, angiogenesis, and immune escape, which provides a perspective for approaching future clinical implications and can be used as biomarkers or therapy.

23 April 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
LMLiviu Moraru
Liviu Moraru
Melinda Ildiko MitranoviciMelinda Ildiko Mitranovici
Melinda Ildiko Mitranovici
Diana Maria ChioreanDiana Maria Chiorean
Diana Maria Chiorean
MCMarius Coroș
Marius Coroș
RMRaluca Moraru
Raluca Moraru
STSabin Turdean
Sabin Turdean
An immature teratoma is a germinal malignant tumor composed of three germ cell layers, occurring more frequently in young women. It is the second most frequent among the malignant germinal tumors after dysgerminoma, and it is the only neoplasm with germ cells that are histologically graded. Even if we do not have a consensus regarding its therapeutical management, it has a good prognosis, with an excellent overall survival rate and good fertility preservation. More studies are needed regarding the necessity of adjuvant chemotherapy in pediatric oncology, and because of chemotherapy’s long-term adverse effects, surveillance or a targeted treatment is preferred, but the main therapy is fertility-sparing surgery. Special attention should be given to the genetic mapping of the histological pieces for patient risk stratification due to its value in prognosis and future treatment.

4 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
Diana Maria ChioreanDiana Maria Chiorean
Diana Maria Chiorean
Melinda Ildiko MitranoviciMelinda Ildiko Mitranovici
Melinda Ildiko Mitranovici
HTHavva Serap Toru
Havva Serap Toru
TCTitiana Cornelia Cotoi Cotoi
Titiana Cornelia Cotoi Cotoi
ATAlexandru Nicusor Tomut
Alexandru Nicusor Tomut
Ovidiu Simion CotoiOvidiu Simion Cotoi
Ovidiu Simion Cotoi
This comprehensive review explores the genetic contributions to endometriosis and their potential impact on improving diagnostic techniques. The review begins by defining endometriosis and discussing its prevalence, emphasizing the need for a deeper understanding of the genetic basis of the condition. It highlights recent genome-wide association studies (GWAS) that have identified specific genetic variants associated with endometriosis, shedding light on the molecular pathways and mechanisms involved. The review addresses genetic heterogeneity across different populations and ethnicities, emphasizing the importance of considering population-specific markers in diagnostic approaches. It explores the diagnostic implications of genetic insights, including the potential use of genetic markers for precise and early detection, as well as risk prediction. The review also delves into the integration of genetic information with clinical parameters and imaging findings, and the exploration of multi-omics approaches for a comprehensive understanding of endometriosis. It discusses recent studies on genetic and epigenetic biomarkers, their potential as diagnostic tools, and the need for validation in independent cohorts. The review highlights the impact of new genomic technologies, such as next-generation sequencing, in improving diagnostic accuracy and personalized management. It identifies the challenges and future directions in translating genetic findings into diagnostic tools and emphasizes the transformative potential of genetic insights in endometriosis diagnosis. This review provides a roadmap for future research and underscores the significance of genetic insights in improving diagnostic precision and personalized care for individuals with endometriosis.

28 May 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
LMLiviu Moraru
Liviu Moraru
Melinda Ildiko MitranoviciMelinda Ildiko Mitranovici
Melinda Ildiko Mitranovici
Diana Maria ChioreanDiana Maria Chiorean
Diana Maria Chiorean
RMRaluca Moraru
Raluca Moraru
LCLaura Georgiana CARAVIA
Laura Georgiana CARAVIA
Ovidiu Simion CotoiOvidiu Simion Cotoi
Ovidiu Simion Cotoi
Cancer arising from adenomyosis is very rare, with transformation occurring in only 1% of cases and in older individuals. Adenomyosis, endometriosis and cancers may share a common pathogenic mechanism that includes hormonal factors, genetic predisposition, growth factors, inflammation, immune system dysregulation, environmental factors and oxidative stress. Endometriosis and adenomyosis both exhibit malignant behaviour. The most common risk factor for malignant transformation is prolonged exposure to oestrogens. The golden standard for diagnosis is histopathology. Colman and Rosenthal emphasised the most important characteristics in adenomyosis-associated cancer. Kumar and Anderson emphasised the importance of demonstrating a transition between benign and malignant endometrial glands in cancer arising from adenomyosis. As it is very rare, it is difficult to standardize treatment. In this manuscript, we try to emphasize some aspects regarding the management strategy, as well as how heterogenous the studies from the literature are in terms of prognosis in both cancers that develop from adenomyosis or those that are only associated with adenomyosis. The pathogenic mechanisms of transformation remain unclear. As these types of cancer are so rare, there is no standardised treatment. A novel target in the diagnosis and treatment of gynaecological malignancies associated with adenomyosis is also being studied for the development of new therapeutic concepts.

9 December 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Melinda Ildiko MitranoviciMelinda Ildiko Mitranovici
Melinda Ildiko Mitranovici
Diana Maria ChioreanDiana Maria Chiorean
Diana Maria Chiorean
MMMaria Cezara Mureșan
Maria Cezara Mureșan
Corneliu-Florin BuicuCorneliu-Florin Buicu
Corneliu-Florin Buicu
RMRaluca Moraru
Raluca Moraru
LPLucian Puscasiu
Lucian Puscasiu
Dysgerminoma represents a rare malignant tumor composed of germ cells, originally from the embryonic gonads. Regarding its incidence, we do not have precise data due to its rarity. Dysgerminoma occurs at a fertile age. The preferred treatment is the surgical removal of the tumor succeeded by the preservation of fertility. Even if a multidisciplinary team, founded in 2009 by a gynecologist, an oncologist, a pediatric oncologist and a pediatric surgeon, under the guidance of the Malignant Germ Cell International Consortium (MaGIC), studies this type of tumor, issues still remain related to the lack of a randomized study and to both the management and understanding of the concept of OMGCTs (ovarian malignant germ cell tumors). The aim of this review is to present from the literature the various approaches for this type of tumor, and, regarding innovative therapies or possible prevention, which can be applied in clinical practice. Multidisciplinarity and treatment in reference centers have proven their usefulness as well.

27 May 2021 in Medicina
Verified
Journal Article
Open access
PDF file
ICIuliu Gabriel Cocuz
Iuliu Gabriel Cocuz
MCMaria-Elena Cocuz
Maria-Elena Cocuz
RNRaluca Niculescu
Raluca Niculescu
MȘMihaela Cornelia Șincu
Mihaela Cornelia Șincu
ATAndreea Catalina Tinca
Andreea Catalina Tinca
Ovidiu Simion CotoiOvidiu Simion Cotoi
Ovidiu Simion Cotoi
Background and Objectives: The COVID-19 pandemic has globally affected health systems and services. Non-melanoma skin cancers (NMSCs) are the most common malignancies around the world. This study aimed to analyze the differences in the benign and malignant histopathological diagnoses performed on radical excision skin tumors and skin biopsies in the dermatopathology ward in Mures Clinical County Hospital, Targu Mures, Romania, 1 year prior to and during the COVID-19 pandemic, to emphasize the changes in the diagnostic process as per the new regulations. Materials and Methods: A total of 1168 histopathological diagnoses were included in the study—302 from the COVID-19 period and 866 from the non-COVID-19 period—considering the number, type, and frequency of the histopathological diagnoses as variables to be analyzed. Results: In the COVID-19 period, out of the 55 NMSC and melanoma histopathological diagnoses, 50.9% (n = 28) were BCCs, 20% (n = 11) were SCCs, 10.9% (n = 6) were basosquamous cell carcinomas, and 18.18% (n = 10) were melanoma cases. Regarding the non-COVID-19 period, out of the 173 NMSC and melanoma histopathological diagnoses, 46.82% (n = 81) were BCCs, 22.54% (n = 39) were SCCs, 7.51% (n = 13) were basosquamous cell carcinomas, and 23.12% (n = 40) were melanoma cases. Conclusions: During the COVID-19 pandemic, a decrease in histopathological diagnoses at the dermatopathology ward in our hospital was observed, for both benign and malignant pathologies, especially for NMSCs and melanomas, compared to the same period 1 year prior to the pandemic.